Hoyoung Huh's Trading History
| AKTXAkari Therapeutics | Oct 16, 2026 | Director, Ten Percent Owner | Uninformative Buy | 136.09K | $1.16M | |
| PKBOPeak Bio | Nov 18, 2024 | ― | Uninformative Sell | ― | $0.00 | |
| GERNGeron | Jan 02, 2018 | Director | Uninformative Buy | ― | $137.95K | |
| RZLTRezolute | Apr 09, 2014 | Director, Ten Percent Owner | Uninformative Buy | 290.87B | ― | |
| NKTRNektar Therapeutics | ― | Director | ― | $310.96K | ||
| PLRXPliant Therapeutics | ― | Director | ― | $205.59K | ||
| EIDXEidos Therapeutics | ― | ― | ― | ― | ||
| CTMXCytomX Therapeutics | ― | Director | ― | ― |
You May Also Like
Hoyoung Huh insider profile FAQ
What stocks does Hoyoung Huh hold?
Hoyoung Huh holds: AKTX, GERN, CTMX, EIDX, PLRX, PKBO, NKTR, RZLT stocks.
What was Hoyoung Huh’s latest transaction?
Hoyoung Huh’s latest transaction was an Uninformative Buy of $136.09K.
What is Hoyoung Huh's role in Akari Therapeutics?
Hoyoung Huh's role in Akari Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.